-
Nektar Therapeutics (NASDAQ:NKTR) Receives Average Recommendation of "Moderate Buy" from Brokerages
Source: Buzz FX / 20 Dec 2024 04:02:11 America/Chicago
Nektar Therapeutics (NASDAQ:NKTR) Receives Average Recommendation of "Moderate Buy" from Brokerages Written by MarketBeat December 20, 2024 Share Link copied to clipboard. Nektar Therapeutics ( NASDAQ:NKTR - Get Free Report ) has received a
Read more...